MedX Health Corp Announces Operating Results For The Six Months ended June 30, 2007

    MISSISSAUGA, ON, Aug. 28 /CNW/ - MedX Health Corp., a leader in the
development, manufacture and distribution of innovative phototherapy devices,
announces its results for the three and six months ended June 30, 2007.
    Revenue for the three months ended June 30, 2007 were $344,885 compared
to $720,595 for the three months ended Jun 30, 2006 a significant decrease
versus the same period last year
    MedX incurred a net loss of $495,952 in Q2 2007 compared to a net loss of
$171,871 for the same period in the prior year.

                                                          6 mos.       6 mos.
    Canadian $                Q2 2007      Q2 2006         2007         2006
    Revenue                   344,885      720,595      657,597    1,519,254
    Gross Margin %                 75%          74%          74%          78%
    Income (Loss) from
     continued operations    (496,070)    (171,042)  (1,040,531)    (284,658)
    Income (Loss) from
     discontinued operations      118         (829)        (789)      (2,551)
    Net Income (Loss)
     for period              (495,952)    (171,871)  (1,041,320)    (287,209)
    Weighted Average no.
     of shares outstanding
     -basic and diluted    15,043,937   15,018,005   15,043,937   14,498,559
    Loss per Common Share
     -basic and diluted        ($0.03)      ($0.01)      ($0.07)      ($0.02)

    "Sales in the quarter were disappointing and as expected, were lower than
last years same quarter due to a restructuring of our distribution network. We
have started an exciting new sales program whereby a number of sales agents
have joined our Rehab marketing effort. We expect this to have a positive
impact on our future results." said Phil Passy, President & CEO of MedX Health

    Significant achievements during the quarter were as follows:
    -   Sales in the Canadian market increased by 10% over the same period
        last year.
    -   Continued development of new light therapy products and intellectual
        property associated thereto.
    -   Introduction of new dental phototherapy device in Canada

    About the Company - MedX, the phototherapy experts, are leaders in the
development, manufacture and distribution of innovative phototherapy medical
devices. MedX products offer effective treatment through a powerful and proven
modality - giving patients a rapid, drug free and non-invasive healing
solution. MedX products are used by practitioners in clinics, academic
facilities, and hospitals as well as by professional athletes and sports teams
to improve quality of life through accelerating healing and reducing pain.
MedX brand products are US FDA and Health Canada cleared and are produced in
an ISO 9001 and 13485 certified manufacturing and testing facility. For a
complete profile of MedX Health Corp. and its products visit

    %SEDAR: 00017466E

For further information:

For further information: Phil Passy, President and CEO, MedX Health
Corp., Telephone: (905) 826-0766, Email:

Organization Profile

MedX Health Corp.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890